Protocol for a feasibility and early efficacy study of the Comprehensive Lifestyle Improvement Program for Prostate Cancer-2 (CLIPP2)

BACKGROUND: Although androgen deprivation therapy (ADT) for prostate cancer demonstrates improved overall and disease-free survival, it is associated with adverse effects such as obesity and metabolic syndrome that increase risk of cardiometabolic disease and diabetes type 2. ADT also leads to fatig...

Descripción completa

Detalles Bibliográficos
Autores principales: Algotar, A.M., Kumar, R., Babiker, H.M., Dougherty, S.T., Hsu, C.H., Chow, H.-H., Smith, T.E., Marrero, D.G., Courneya, K.S., Abraham, I., Ligibel, J.A., Thomson, C.A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815988/
https://www.ncbi.nlm.nih.gov/pubmed/33511299
http://dx.doi.org/10.1016/j.conctc.2021.100701

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815988/
https://www.ncbi.nlm.nih.gov/pubmed/33511299
http://dx.doi.org/10.1016/j.conctc.2021.100701

Ejemplares similares